ADMA Biologics Inc (ADMA) vs Recursion Pharmaceuticals, Inc. (RXRX)

ADMA Biologics Inc and Recursion Pharmaceuticals, Inc. are both Biotechnology companies. ADMA Biologics Inc and Recursion Pharmaceuticals, Inc. are of similar size ($2.1B and $2.1B). Recursion Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; ADMA Biologics Inc trades at 13.0×. ADMA Biologics Inc grew revenue faster over the last twelve months: 8.04% against −15.1%. ADMA Biologics Inc has the higher net margin (33.0% vs −945.9%) and the higher return on invested capital (29.8% vs −92.2%). Across the 18 metrics below, ADMA Biologics Inc leads on 15 and Recursion Pharmaceuticals, Inc. on 3.